Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo

Breast Cancer Research and Treatment

Volumn 104, Issue 2, 2007, Pages 211-219

  Ishida, Hiroyuki ^a   Nakata, Taisuke ^a   Sato, Natsuko ^a   Li, Pui Kai ^b   Kuwabara, Takashi ^a   Akinaga, Shiro ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Breast cancer; Estrone sulfate; Inhibitor; Steroid sulfatase

Indexed keywords

ESTRADIOL; ESTRONE SULFATE; KW 2581; STERYL SULFATASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG SCREENING; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; COUMARINS; ENZYME INHIBITORS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR STRUCTURE; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; STERYL-SULFATASE; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 34447558569     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9404-8     Document Type: Article

References (28)

1. Henderson IC, Canellos GP (1980) Cancer of the breast: the past decade. N Engl J Med 302:17-30
2. Suzuki T, Moriya T, Ishida T, Ohuchi N, Sasano H (2003) Intracrine mechanism of estrogen synthesis in breast cancer. Biomed Pharmacother 57:460-462
3. Miller WR, Dixon JM (2001) Local endocrine effects of aromatase inhibitors within the breast. J Steroid Biochem Mol Biol 79:93-102
4. Reed MJ, Owen AM, Lai LC, Coldham NG, Ghilchik MW, Shaikh NA, James VH (1989) In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione. Int J Cancer 44:233-237
5. MacIndoe JH (1988) The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. Endocrinology 123:1281-1287
6. Prost O, Turrel MO, Dahan N, Craveur C, Adessi GL (1984) Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma. Cancer Res 44:661-664
7. Abul-Hajj YJ, Iverson R, Kiang DT (1979) Related articles on aromatization of androgens by human breast cancer. Steroids 33:205-222
8. Lipton A, Santner SJ, Santen RJ, Harvey HA, Feil PD, White-Hershey D, Bartholomen MJ, Antle CE (1987) Aromatase activity in primary and metastatic human breast cancer. Cancer 59:779-782
9. Perel E, Daniilescu D, Kharlip L, Blackstein M, Killinger DW (1988) Steroid modulation of aromatase activity in human cultured breast carcinoma cells. J Steroid Biochem 29:393-399
10. Abul-Hajj YJ (1979) Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer. Steroids 34:217-225
11. Vermeulen A, Deslypere JP, Paridaens R, Leclercq G, Roy F, Heuson JC (1986) Aromatase, 17 ß-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer Clin Oncol 22:515-525
12. Utsumi T, Yoshimura N, Takeuchi S, Ando J, Maruta M, Maeda K, Harada N (1999) Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer. Cancer Res 59:377-381
13. Miyoshi Y, Ando A, Hasegawa S, Ishitobi M, Taguchi T, Tamaki Y, Noguchi S (2003) High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. Clin Cancer Res 9:2288-2293
14. Suzuki T, Nakata T, Miki Y, Kaneko C, Moriya T, Ishida T, Akinaga S, Hirakawa H, Kimura M, Sasano H (2003) Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res 63:2762-2770
15. Stanway SJ, Purohit A, Woo LW, Sufi S, Vigushin D, Ward R, Wilson RH, Stanczyk FZ, Dobbs N, Kulinskaya E, Elliott M, Potter BV, Reed MJ, Coombes RC (2006) Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clin Cancer Res 12:1585-1592
16. Nakata T, Takashima S, Shiotsu Y, Murakata C, Ishida H, Akinaga S, Li PK, Sasano H, Suzuki T, Saeki T (2003) Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients. J Steroid Biochem Mol Biol 86:455-460
17. Demirpence E, Balaguer P, Trousse F, Nicolas JC, Pons M, Gagne D (1994) Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 54:1458-1464
18. LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS (2002) 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 62:3691-3697
19. Billich A, Nussbaumer P, Lehr P (2000) Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. J Steroid Biochem Mol Biol 73:225-235
20. Evans TR, Rowlands MG, Luqmani YA, Chander SK, Coombes RC (1993) Detection of breast cancer-associated estrone sulfatase in breast cancer biopsies and cell lines using polymerase chain reaction. J Steroid Biochem Mol Biol 46:195-201
21. Santner SJ, Feil PD, Santen RJ (1984) In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab 59:29-33
22. James MR, Skaar TC, Lee RY, MacPherson A, Zwiebel JA, Ahluwalia BS, Ampy F, Clarke R (2001) Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo. Endocrinology 142:1497-1505
23. Seibert K, Shafie SM, Triche TJ, Whang-Peng JJ, O'Brien SJ, Toney JH, Huff KK, Lippman ME (1983) Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res 43:2223-2239
24. Brunner N, Svenstrup B, Spang-Thomsen M, Bennett P, Nielsen A, Nielsen J (1986) Serum steroid levels in intact and endocrine ablated BALB/c nude mice and their intact littermates. J Steroid Biochem 25:429-432
25. Woo LL, Purohit A, Malini B, Reed MJ, Potter BV (2000) Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates. Chem Biol 7:773-791
26. Purohit A, Williams GJ, Howarth NM, Potter BV, Reed MJ (1995) Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Biochemistry 34:11508-11514
27. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9:1603-1614
28. Peters RH, Chao WR, Sato B, Shigeno K, Zaveri NT, Tanabe M (2003) Steroidal oxathiazine inhibitors of estrone sulfatase. Steroids 68:97-110